SE0101325D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
SE0101325D0
SE0101325D0 SE0101325A SE0101325A SE0101325D0 SE 0101325 D0 SE0101325 D0 SE 0101325D0 SE 0101325 A SE0101325 A SE 0101325A SE 0101325 A SE0101325 A SE 0101325A SE 0101325 D0 SE0101325 D0 SE 0101325D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
SE0101325A
Other languages
Swedish (sv)
Inventor
Hans Carlsson
Anette Larsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101325A priority Critical patent/SE0101325D0/en
Publication of SE0101325D0 publication Critical patent/SE0101325D0/en
Priority to TW091106494A priority patent/TWI259836B/en
Priority to ARP020101188A priority patent/AR035807A1/en
Priority to MYPI20021315A priority patent/MY141595A/en
Priority to MXPA03009213A priority patent/MXPA03009213A/en
Priority to EEP200300506A priority patent/EE200300506A/en
Priority to BR0208830-4A priority patent/BR0208830A/en
Priority to US10/474,591 priority patent/US20040132798A1/en
Priority to RU2003129229/04A priority patent/RU2003129229A/en
Priority to SK1254-2003A priority patent/SK12542003A3/en
Priority to EP02723010A priority patent/EP1389211A1/en
Priority to CZ20032759A priority patent/CZ20032759A3/en
Priority to HU0303481A priority patent/HUP0303481A3/en
Priority to PL02367182A priority patent/PL367182A1/en
Priority to IL15803502A priority patent/IL158035A0/en
Priority to NZ528559A priority patent/NZ528559A/en
Priority to JP2002581442A priority patent/JP2004525969A/en
Priority to KR10-2003-7013419A priority patent/KR20040005917A/en
Priority to PCT/SE2002/000724 priority patent/WO2002083687A1/en
Priority to CA002443464A priority patent/CA2443464A1/en
Priority to CNB028116348A priority patent/CN1279916C/en
Priority to ZA200307757A priority patent/ZA200307757B/en
Priority to BG108235A priority patent/BG108235A/en
Priority to NO20034528A priority patent/NO20034528L/en
Priority to IS6990A priority patent/IS6990A/en

Links

SE0101325A 2001-04-12 2001-04-12 Pharmaceutical formulation SE0101325D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE0101325A SE0101325D0 (en) 2001-04-12 2001-04-12 Pharmaceutical formulation
TW091106494A TWI259836B (en) 2001-04-12 2002-04-01 Modified release formulation suitable for antiarrhythmic compounds
ARP020101188A AR035807A1 (en) 2001-04-12 2002-04-02 PHARMACEUTICAL COMPOSITION OF APPROPRIATE MODIFIED LIBERATION FOR ANTIARRITHMIC COMPOUNDS, PROCEDURE FOR PREPARATION, AND USE OF THIS COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE PROPHYLAXIS OR TREATMENT OF ARRITMIA
MYPI20021315A MY141595A (en) 2001-04-12 2002-04-10 New modified release formulation suitable for antiarrhythmic compounds
CNB028116348A CN1279916C (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds
EP02723010A EP1389211A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo 3.3.1] formulations as antiarrhytmic compounds
NZ528559A NZ528559A (en) 2001-04-12 2002-04-12 Oxabispidine compounds in delayed and sustained release pharmaceutical compositions
BR0208830-4A BR0208830A (en) 2001-04-12 2002-04-12 Modified release pharmaceutical composition, process for preparing a composition, use of a composition, and method of prophylaxis or treatment of an arrhythmia
US10/474,591 US20040132798A1 (en) 2001-04-12 2002-04-12 3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds
RU2003129229/04A RU2003129229A (en) 2001-04-12 2002-04-12 3,7-DIAZABicyclo [3.3.1] - DRUGS AS ANTIARRHYTHMIC COMPOUNDS
SK1254-2003A SK12542003A3 (en) 2001-04-12 2002-04-12 3,7-Diazabicyclo-[3.3.1] formulations as antiarrhytmic compounds
MXPA03009213A MXPA03009213A (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds.
CZ20032759A CZ20032759A3 (en) 2001-04-12 2002-04-12 Pharmaceutical composition containing 3,7-diazabicyclo[3,3,1]-derivatives as an active component and use thereof
HU0303481A HUP0303481A3 (en) 2001-04-12 2002-04-12 Compositions containing 3,7-diazybicyclo[3,3,1]compounds as antiarrhytmic agents
PL02367182A PL367182A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo[3.3.1] formulations as antiarrhytmic compounds
IL15803502A IL158035A0 (en) 2001-04-12 2002-04-12 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
EEP200300506A EE200300506A (en) 2001-04-12 2002-04-12 Preparations of 3,7-diazabicyclo [3.3.1], methods for their preparation and their use in the prophylaxis or treatment of cardiac arrhythmias
JP2002581442A JP2004525969A (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] preparation as antiarrhythmic compound
KR10-2003-7013419A KR20040005917A (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3,3,1] formulations as antiarrhythmic compounds
PCT/SE2002/000724 WO2002083687A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
CA002443464A CA2443464A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
ZA200307757A ZA200307757B (en) 2001-04-12 2003-10-03 3,7-Diazabicyclo[3.3.1]formulations as antiarrhythmic compounds.
BG108235A BG108235A (en) 2001-04-12 2003-10-06 3,7-diazabicyclo[3,3,1] formulations as antiarrhythmic compounds
NO20034528A NO20034528L (en) 2001-04-12 2003-10-09 3,7-diazabicyclo (3,3,1) formulations as antiarrhythmic compounds
IS6990A IS6990A (en) 2001-04-12 2003-10-10 3,7-diazabicyclo [3.3.1] preparations as antithrombotic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101325A SE0101325D0 (en) 2001-04-12 2001-04-12 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE0101325D0 true SE0101325D0 (en) 2001-04-12

Family

ID=31885206

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101325A SE0101325D0 (en) 2001-04-12 2001-04-12 Pharmaceutical formulation

Country Status (2)

Country Link
SE (1) SE0101325D0 (en)
ZA (1) ZA200307757B (en)

Also Published As

Publication number Publication date
ZA200307757B (en) 2005-01-03

Similar Documents

Publication Publication Date Title
NO20033384D0 (en) Pharmaceutical formulation
NO20033785D0 (en) Pharmaceutical formulation
NO20033556L (en) Pharmaceutical Formulations
ITTO20010008A0 (en) PHARMACEUTICAL FORMULATION
FI20011478A (en) Pharmaceutical composition
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
NO20035627D0 (en) Pharmaceutical formulation
EE200300589A (en) Pharmaceutical compositions
DE50209245D1 (en) NEUROPROTEKTIVES MEDICAMENT
FI20022128A (en) Pharmaceutical composition
NO20042502L (en) Pharmaceutical formulation comprising bicalutamide
NO20041485L (en) Pharmaceutical formulation comprising (R) -bicalutamide
AR025867A1 (en) PHARMACEUTICAL PORTASDORA FORMULATION
DE10291905D2 (en) Pharmaceutical composition
NO20015534D0 (en) Pharmaceutical mixer
EE200300465A (en) Pharmaceutical compositions based on pyridoindolone derivatives
DE10107261B4 (en) Pharmaceutical composition
NO20041236L (en) Pharmaceutical Formulation
FI20012242A0 (en) New pharmaceutical compounds
SE0103565D0 (en) Pharmaceutical formulation
SE0102572D0 (en) Pharmaceutical formulation
SE0102957D0 (en) Pharmaceutical formulation
SE0101325D0 (en) Pharmaceutical formulation
SE0101171D0 (en) Pharmaceutical formulation
SE0101326D0 (en) Pharmaceutical formulation